Literature DB >> 19012968

Economic costs of social phobia: a population-based study.

C Acarturk1, Filip Smit, R de Graaf, A van Straten, M Ten Have, P Cuijpers.   

Abstract

BACKGROUND: Information about the economic costs of social phobia is scant. In this study, we examine the economic costs of social phobia and subthreshold social phobia.
METHODS: Data were derived from the Netherlands Mental Health Survey and Incidence Study (NEMESIS) which is a population-based prospective study (n=4,789). Costs related to health service uptake, patients' out-of-pocket expenses, and costs arising from production losses were calculated for the reference year 2003. The costs for people with social phobia were compared with the costs for people with no mental disorder.
RESULTS: The annual per capita total costs of social phobia were euro 11,952 (95% CI=7,891-16,013) which is significantly higher than the total costs for people with no mental disorder, euro 2957 (95% CI=2690-3224). When adjusting for mental and somatic co-morbidity, the costs decreased to euro 6,100 (95% CI=2681-9519), or 136 million euro per year per 1 million inhabitants, which was still significantly higher than the costs for people with no mental disorder. The costs of subthreshold social phobia were also significantly higher than the costs for people without any mental disorder, at euro 4,687 (95% CI=2557-6816). LIMITATIONS: The costs presented here are conservative lower estimates because we only included costs related to mental health services.
CONCLUSIONS: The economic costs associated with social phobia are substantial, and those of subthreshold social phobia approach those of the full-blown disorder.

Entities:  

Mesh:

Year:  2008        PMID: 19012968     DOI: 10.1016/j.jad.2008.10.008

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  22 in total

Review 1.  Economic Burden of Anxiety Disorders: A Systematic Review and Meta-Analysis.

Authors:  Alexander Konnopka; Hannah König
Journal:  Pharmacoeconomics       Date:  2020-01       Impact factor: 4.981

2.  Clinical presentation and pharmacotherapy response in social anxiety disorder: The effect of etiological beliefs.

Authors:  Jonah N Cohen; Carrie M Potter; Deborah A G Drabick; Carlos Blanco; Franklin R Schneier; Michael R Liebowitz; Richard G Heimberg
Journal:  Psychiatry Res       Date:  2015-04-16       Impact factor: 3.222

Review 3.  A systematic review of treatments targeting cognitive biases in socially anxious adolescents: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD.

Authors:  Bruno Biagianti; Christine Conelea; Paolo Brambilla; Gail Bernstein
Journal:  J Affect Disord       Date:  2019-12-03       Impact factor: 4.839

Review 4.  Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.

Authors:  Janine V Olthuis; Margo C Watt; Kristen Bailey; Jill A Hayden; Sherry H Stewart
Journal:  Cochrane Database Syst Rev       Date:  2016-03-12

5.  Trajectories of social anxiety, cognitive reappraisal, and mindfulness during an RCT of CBGT versus MBSR for social anxiety disorder.

Authors:  Philippe R Goldin; Amanda S Morrison; Hooria Jazaieri; Richard G Heimberg; James J Gross
Journal:  Behav Res Ther       Date:  2017-06-03

6.  Changes in Positive Self-Views Mediate the Effect of Cognitive-Behavioral Therapy for Social Anxiety Disorder.

Authors:  Philippe R Goldin; Hooria Jazaieri; Michal Ziv; Helena Kraemer; Richard Heimberg; James J Gross
Journal:  Clin Psychol Sci       Date:  2013-07

7.  Group CBT versus MBSR for social anxiety disorder: A randomized controlled trial.

Authors:  Philippe R Goldin; Amanda Morrison; Hooria Jazaieri; Faith Brozovich; Richard Heimberg; James J Gross
Journal:  J Consult Clin Psychol       Date:  2016-03-07

Review 8.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

9.  Anxiety trajectories in response to a speech task in social anxiety disorder: Evidence from a randomized controlled trial of CBT.

Authors:  Amanda S Morrison; Faith A Brozovich; Ihno A Lee; Hooria Jazaieri; Philippe R Goldin; Richard G Heimberg; James J Gross
Journal:  J Anxiety Disord       Date:  2015-12-29

10.  Cognitive reappraisal self-efficacy mediates the effects of individual cognitive-behavioral therapy for social anxiety disorder.

Authors:  Philippe R Goldin; Michal Ziv; Hooria Jazaieri; Kelly Werner; Helena Kraemer; Richard G Heimberg; James J Gross
Journal:  J Consult Clin Psychol       Date:  2012-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.